iResearch Atlanta will join the Global Alzheimer’s Platform Foundation®’s network (GAP-Net) of clinical trial sites working to bring new treatments to those living with the disease and and improve equity in research.
Contact: Peter Buonanno – peterbuonanno@rational360.com – 704.989.5501
WASHINGTON, D.C. (December 7, 2021) – The Global Alzheimer’s Platform Foundation® (GAP) announced that iResearch Atlanta will join its network of clinical trial sites (GAP-Net), a team of leading academic and private research sites collaborating to accelerate the delivery of innovative therapies for neurological disorders by reducing the duration and cost of clinical trials and improving equity in trial recruitment. As a GAP-Net member, iResearch Atlanta will continue to make a difference in its local community as they conduct research studies of new treatments and therapies medications for illnesses affecting the Atlanta community, including Alzheimer’s disease.
“iResearch Atlanta will help increase the availability of Alzheimer’s clinical trials in a quickly-growing market with a high prevalence of the disease,” said John Dwyer, President of GAP. “The teams at iResearch Atlanta will specifically help bring clinical trials to people from traditionally underrepresented communities in the area.”
Across the country, Black Americans are between two-and-three times more likely to develop Alzheimer’s in their lifetimes. At the local level, 50% of Atlanta residents identify as Black or African American. Additionally, there are an estimated 150,000 people living with Alzheimer’s in Georgia – and that number is expected to increase to 190,000 by 2025. iResearch has a proven capability to fill studies quickly through extensive community engagement and is committed to enrolling participants from a broad demographic range to ensure that future treatments are sensitive and specific to all people.
“iResearch Atlanta is led by dedicated, experienced research professionals who are committed to conducting clinical trials which help bring effective treatments to our local and global communities while ensuring that study participants have a customized and respectful experience,” said Heather Beitz, co-owner of iResearch Atlanta. “Collaborating with other GAP-Net sites who share our values will help us alter the clinical trial landscape in the U.S. through improved and intentional recruitment, and unbiased data collection.”
iResearch Atlanta is a multi-specialty clinical research center in Decatur, GA outside of Atlanta. The center was founded in 2010 by Heather Beitz, Chief Executive Officer and Clinical Operations Director, and Sara Castle, Chief Operations Officer. The center’s team is composed of practitioners with extensive experience in pharmaceutical and medical device research across a wide range of therapeutic areas, including major neurocognitive disorders like Alzheimer’s disease and Parkinson’s disease.
Those interested in enrolling in an Alzheimer’s clinical trial at iResearch can and its reach can visit www.iResearchAtlanta.com or email info@globalalzplatform.org.
###
About the Global Alzheimer’s Platform Foundation® (GAP)
The Global Alzheimer’s Platform Foundation® (GAP) is a person-centric nonprofit dedicated to accelerating the delivery of innovative therapies for neurological disorders by reducing the duration and cost of clinical trials. Research centers across the US, Canada, and Europe are part of the growing GAP Network (GAP-Net). GAP supports GAP-Net research centers by assisting with study start up and recruitment activities, promoting diversity in research studies, and offering national programs that champion brain health and the citizen scientists who make research possible.